医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial

广告
作者单位: University of Utrecht, Utrecht, Netherlands [1] University of Glasgow, Glasgow, United Kingdom [2] University Hospital Basel, Basel, Switzerland [3] Medical University of Warsaw, Warsaw, Poland [4] Hospital Geral de Santo Antonio, Porto, Portugal [5] Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Canada [6] Department of Neurology ASL1, Ospedale, Citta' di Castello, Italy [7] McMaster University, ON, Canada [8] Royal Perth Hospital, Perth, Australia [9] Oxford University, Oxford, United Kingdom [10] Division of Clinical Neuroscience, University of Edinburgh, Edinburgh, United Kingdom [11] Nottingham University, Nottingham, United Kingdom [12] University of Manchester, Manchester, United Kingdom [13] Oslo University Hospital, Oslo, Norway [14] Sydney Medical School, Westmead Hospital, University of Sydney, Australia [15] University of Edinburgh, Division of Clinical Neurosciences, Western General Hospital, Crewe Road [16] University of Oxford, Oxford, United Kingdom [17] Landesklinikum Donauregion Tulln, Tulln, Austria [18] Instituto Nacional de Neurologia, Mexico City, Mexico [19] University of Liverpool, Liverpool, United Kingdom [20] Cliniques Universitaires Saint-Luc, Bruxelles, Belgium [21] Karolinska Institutet, Stockholm, Sweden [22] Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom [23] Clinical Trials Service Unit, Oxford, United Kingdom [24]
发布时间 2013-11-20
提交
  • 浏览3
The Lancet

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷